These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16989912)

  • 1. Dose-dependent Venlafaxine-induced sinus tachycardia.
    Abozguia K; Chudley S; Gammage M
    Int J Cardiol; 2006 Oct; 113(1):E9-10. PubMed ID: 16989912
    [No Abstract]   [Full Text] [Related]  

  • 2. Very low dose quetiapine-induced galactorrhea in combination with venlafaxine.
    Pae CU; Kim JJ; Lee CU; Chae JH; Lee SJ; Lee C; Paik IH
    Hum Psychopharmacol; 2004 Aug; 19(6):433-4. PubMed ID: 15303249
    [No Abstract]   [Full Text] [Related]  

  • 3. Mania after venlafaxine withdrawal in a patient with generalized anxiety disorder.
    Khazaal Y
    Ann Pharmacother; 2007 Feb; 41(2):359-60. PubMed ID: 17284507
    [No Abstract]   [Full Text] [Related]  

  • 4. Venlafaxine: loss of antidepressant effect and its management.
    Sharma V
    J Clin Psychiatry; 1998 Jul; 59(7):381-2. PubMed ID: 9714268
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose-related increase of intraocular pressure caused by venlafaxine use: case report.
    Della Mônica M; D'Elia G; de Andrade AG; Alves TC
    J Clin Psychopharmacol; 2008 Apr; 28(2):252-4. PubMed ID: 18344748
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose venlafaxine-induced severe rhabdomyolysis: a case report.
    Huang SS; Yang HY; Lin YC; Chan CH
    Gen Hosp Psychiatry; 2012; 34(4):436.e5-7. PubMed ID: 22459996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of venlafaxine with bupropion: risks associated with a triple monoamine reuptake inhibition approach to partially responsive depression.
    Andrade C
    J Clin Psychiatry; 2013 Feb; 74(2):e119-21. PubMed ID: 23473356
    [No Abstract]   [Full Text] [Related]  

  • 8. [Not neglecting therapy of depression in the elderly].
    MMW Fortschr Med; 2006 Apr; 148(16):56-7. PubMed ID: 16688953
    [No Abstract]   [Full Text] [Related]  

  • 9. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
    Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
    J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-related hyperprolactinemia induced by venlafaxine.
    Yang MS; Cheng WJ; Huang MC
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):733-4. PubMed ID: 19303910
    [No Abstract]   [Full Text] [Related]  

  • 11. Bruxism possibly induced by venlafaxine.
    Alonso-Navarro H; Martín-Prieto M; Ruiz-Ezquerro JJ; Jiménez-Jiménez FJ
    Clin Neuropharmacol; 2009; 32(2):111-2. PubMed ID: 19512964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
    Krol DG; Nolen WA
    Tijdschr Psychiatr; 2006; 48(5):405-8. PubMed ID: 16956033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of venlafaxine in children and adolescents: a review of current literature.
    Weller EB; Weller RA; Davis GP
    Depress Anxiety; 2000; 12 Suppl 1():85-9. PubMed ID: 11098420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotension caused by therapeutic doses of venlafaxine: case report and proposed pathophysiological mechanisms.
    Alexandrino-Silva C; Nadalini Mauá FH; de Andrade AG; de Toledo Ferraz Alves TC
    J Psychopharmacol; 2008 Mar; 22(2):214-6. PubMed ID: 18208934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venlafaxine and tardive blepharospasm: a case report.
    Lee Y; Yeh WC; Chong MY; Lin PY; Chang YY
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1139-40. PubMed ID: 17478026
    [No Abstract]   [Full Text] [Related]  

  • 16. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
    Bloem BR; Roofthooft DW; Lammers GJ; de Beaufort AJ; Brouwer OF
    Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1885-6; author reply 1886. PubMed ID: 14533505
    [No Abstract]   [Full Text] [Related]  

  • 17. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
    Amsterdam JD; Shults J
    J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venlafaxine drug-drug interactions in clinical practice.
    Benazzi F
    J Psychiatry Neurosci; 1998 May; 23(3):181-2. PubMed ID: 9595894
    [No Abstract]   [Full Text] [Related]  

  • 19. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Syndrome of inappropriate antidiuretic hormone secretion in the course of treatment with venlafaxine--case report].
    Chojnacka M; Swiecicki Ł
    Psychiatr Pol; 2011; 45(6):933-9. PubMed ID: 22335135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.